Joyant Pharmaceuticals, Inc.

Joyant Pharmaceuticals, Inc.

Joyant Pharmaceuticals, Inc.

Date Founded



2600 North Stemmons Freeway,Suite 2620,Dallas, TX 75207

Type of Company



Retail: Drug Stores

Company Description

Joyant Pharmaceuticals is a Dallas-based drug discovery company focused on the development of small molecule therapeutics for cancer. Their core competencies include chemical synthesis biochemistry, cell biology, and pharmacology. The focus of its company is on the development of unique chemical entities that operate by new cellular mechanisms. Its understanding of the molecular events that control the growth, replication, and apoptosis of human cells is becoming increasingly sophisticated. They intend to translate new knowledge of such pathways, and their misregulation in disease, into signaling-based targeted therapeutics.

Executives & Employees



Chief Financial Officer


Paths to Joyant Pharmaceuticals, Inc.
Potential Connections via
Relationship Science
Joyant Pharmaceuticals, Inc.
Details Hidden

Co-Founder at BeiGene Ltd.

Details Hidden

Co-Founder at Joyant Pharmaceuticals, Inc.

Details Hidden

Sanderling Ventures is an active manager which provides financing for seed and early-stage capital requirements, as well as providing management support. The firm also engages in syndicate investments for further rounds of financing. Sanderling Ventures invests in young companies operating in the health technology sector, as well as in biotechnology and pharmaceutical industries located in the US. The firm looks to take minority stake positions in its investments and as a seat on the board.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Joyant Pharmaceuticals, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Joyant Pharmaceuticals, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Joyant Pharmaceuticals, Inc..